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Abstract 
Aims: During β-adrenergic receptor (β-AR) stimulation, phosphorylation of 
cardiomyocyte ryanodine receptors (RyRs) by protein kinases may contribute to an 
increased diastolic Ca2+ spark frequency. Regardless of prompt activation of PKA during 
β-AR stimulation, this appears to rely more on activation of CaMKII, by a not yet 
identified signaling pathway. The goal of the present study was to identify and 
characterize the mechanisms which lead to CaMKII activation and elevated Ca2+ spark 
frequencies during β-AR stimulation in single cardiomyocytes in diastolic conditions. 
 
Methods and results: Confocal imaging revealed that β-AR stimulation increases 
endogenous NO production in cardiomyocytes, resulting in NO-dependent activation of 
CaMKII and a subsequent increase of diastolic Ca2+ spark frequency. These changes of 
spark frequency could be mimicked by exposure to the NO donor GSNO and were 
sensitive to the CaMKII inhibitors KN-93 and AIP. In-vitro, CaMKII became nitrosated 
and its activity remained increased independent of Ca2+ in the presence of GSNO, as 
assessed with biochemical assays. 
 
Conclusions: β-AR stimulation of cardiomyocytes may activate CaMKII by a novel 
direct pathway involving NO, without requiring Ca2+ transients. This crosstalk between 
two established signaling pathways may contribute to arrhythmogenic diastolic Ca2+ 
release and Ca2+ waves during adrenergic stress, particularly in combination with cardiac 
diseases. In addition, NO dependent activation of CaMKII is likely to have repercussions 
in many cellular signaling systems and cell types. 
 
Keywords: CaMKII; Ca sparks; Ca waves; NO-synthase 
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1. Introduction 
 
In cardiac excitation-contraction coupling (EC-coupling) Ca2+-induced Ca2+ release 
(CICR) is the mechanism that amplifies the Ca2+ signal initiated by entry of Ca2+ via 
voltage-dependent Ca2+ channels.1 During each systole, CICR generates a robust Ca2+ 
transient by releasing Ca2+ from the sarcoplasmic reticulum (SR) via Ca2+ release 
channels (a.k.a. ryanodine receptors or RyRs). These are macromolecular complexes 
located in diadic clefts, microdomains of junctional SR, in close apposition to L-type Ca2+ 
channels.2 Each group of RyRs and L-type Ca2+ channels forms a unit called couplon 
which can create elementary Ca2+ release events, Ca2+ sparks.3 Faithful RyR functioning 
is crucial in the context of cardiac muscle Ca2+ release, its synchronization and strength 
of contraction. Disturbances of these elementary mechanisms have been observed 
during various cardiac pathologies.4,5 
Upon β-adrenergic receptor (β-AR) stimulation during emotional stress or physical 
exercise, key proteins of Ca2+ signaling, such as the L-type Ca2+ channels, the RyRs and 
phospholamban are phosphorylated by protein kinases,6,7 enhancing Ca2+ cycling. There 
is recent evidence indicating that elevated phosphorylation levels of the RyR mediated 
by protein kinase A (PKA) and Ca2+/calmodulin-dependent protein kinase II (CaMKII) 
may increase their activity8-11 (for reviews see7,12). During chronic β-AR stimulation, this 
could constitute a Ca2+ leak and deplete the SR of Ca2+, which would reduce the 
amplitude of Ca2+ transients, eventually contributing to weak heartbeats.13  
Experimentally, it has proven difficult to clearly assign a role for the different kinases in 
modulating RyR behavior. The generation of various transgenic mouse lines, specifically 
targeting phosphorylation by PKA and CaMKII, has not clarified the situation and 
provided apparently contradictory results and interpretations. However, analysis of Ca2+ 
spark frequencies in transgenic mice expressing constitutively phosphorylated RyRs 
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(S2808D, S2814D) suggested that PKA and CaMKII-dependent phosporylation may 
increase resting Ca2+ spark frequencies.5,9 
Here we examined Ca2+ sparks as signals closely reflecting RyR open probability in their 
native environment. While there is controversial literature on the relative importance of 
PKA and/or CaMKII-dependent RyR phosphorylation,8,14 only few studies specifically 
investigated changes of Ca2+ spark frequencies resulting from β-AR stimulation during 
diastole or in resting cardiomyocytes.5,9,15,16 Based on these findings, it has been 
suggested that PKA-dependent phosphorylation of RyRs may not be significantly 
involved in the observed increase of the resting Ca2+ spark frequency. It has been 
reported that this entirely hinged on the SERCA stimulation resulting from 
phosphorylation of phospholamban17 or occurred via a pathway that could involve 
CaMKII.14,16,18-20 Since the CaMKII-dependent increase of spontaneous spark 
frequencies was observed in resting cardiomyocytes without detectable Ca2+ signals, 
which are typically required for significant Ca2+-dependent activation of CaMKII,21,22 it 
remained unresolved by which pathway(s) CaMKII would become activated under these 
conditions. 
The current study represents an effort to reveal the mechanism involved in the activation 
of CaMKII in resting cardiomyocytes during β-AR stimulation, and to identify an 
alternative pathway that could underlie the observed increase in Ca2+ spark frequency. 
In the literature, several possible mechanisms have been mentioned. The “exchange 
protein activated by cAMP” (Epac) may participate in the modulation of RyR open 
probability, either directly or via CaMKII.18 Another alternative is activation of CaMKII by 
reactive oxygen species (ROS), which is known to occur independently of detectable 
Ca2+ signals.23 Therefore, we carried out experiments investigating Ca2+ sparks and 
CaMKII activity to characterize the putative involvement of these and other cellular 
signaling pathways. 
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Together our findings reveal that upon β-AR stimulation CaMKII becomes activated in a 
manner that does not require Ca2+ transients, initiated by formation of endogenous nitric 
oxide (NO). This represents an unexpected and newly discovered mode of CaMKII 
activation occurring in parallel to PKA. Preliminary findings have previously been 
presented in abstract form.24
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2. Methods 
For additional information on methods, see Supplementary information online. 
 
2.1 Isolation of Guinea-pig ventricular myocytes 
For all electrophysiological and confocal Ca2+ and NO imaging experiments, we used 
freshly isolated Guinea-pig ventricular cardiomyocytes16 following the animal handling 
procedures conforming with the National Institutes of Health Guide for the Care and Use 
of Laboratory Animals (1996) and with the permission of the State Veterinary 
Administration and according to Swiss Federal Animal protection law (permit BE97/09). 
Animals were euthanized by stunning and cervical dislocation, followed by rapid removal 
and enzymatic dissociation of the cardiac tissue. 
 
2.2 Experimental solutions 
All drugs, inhibitors and donors used during our experiments were freshly prepared daily 
from aliquots. Extracellular and intracellular (patch pipette) solutions were used from a 
ready made stock.16 
 
2.3 Electrophysiological recordings 
ICa recordings were carried out in the whole-cell configuration of the patch clamp 
technique, resting membrane potential was set at -80mV during Ca2+ imaging.16 
 
2.4 SR Ca2+ content preconditioning 
To ensure a constant SR Ca2+ content, we performed a SR Ca2+ loading protocol with a 
train of 20 membrane depolarizations from -80 to 0 mV (see Figure 1A). 
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Pharmacological interventions were applied, as indicated. Changes in SR Ca2+ content 
were compared to control conditions without the drug, after an identical loading protocol. 
In all cases content was estimated by recording a Ca2+ transient triggered with caffeine.  
2.5 Confocal Ca2+ and NO imaging 
The Ca2+ spark frequency and SR Ca2+ content are shown after normalization and 
expressed as mean values ±S.E.M. For these recordings we used fluo-3 as Ca2+ 
indicator. NO measurements were carried out using DAF-2DA. Confocal imaging was 
performed with either a FluoView-1000 (Olympus) or a MRC-1000 confocal laser-
scanning microscope (Bio-Rad). Indicators were excited at 488 nm with a solid-state 
laser (Sapphire 488-10) and fluorescence was detected > 515 nm. 
 
2.6 In-vitro CaMKIIδ activity and nitrosation assays 
Ca2+-independent, H2O2 and NO-dependent CaMKII activities were assessed by using 
an ELISA kit. Values are shown normalized to the maximal CaMKII activation levels 
reached in low Ca2+ (<10 nM Ca2+; CaM/EGTA). Nitrosation of CaMKII was quantified 
using an antibody specifically detecting S-nitrosated cysteines. 
 
2.7 Statistics 
Paired or unpaired Students t-tests were applied as appropriate to determine 
significance. In figures p values of < 0.05 or < 0.01 are indicated by * or **, respectively. 
N refers to number of animals, n to number of cells.
 at Fachbereichsbibliothek on A
ugust 20, 2013
http://cardiovascres.oxfordjournals.org/
D
ow
nloaded from
 
A
cc
ep
te
d 
M
an
us
cr
ip
t
8 
3. Results 
 
3.1 Ca2+ spark frequency during β-AR stimulation is modulated by CaMKII but not 
PKA 
 
We investigated cAMP-dependent pathways (e.g. PKA, Epac) to determine the 
involvement of PKA and/or CaMKII in the modulation of resting Ca2+ spark frequencies. 
Constant SR loading was achieved with Ca2+ preloading involving a train of L-type Ca2+ 
currents. SR Ca2+ content was estimated with caffeine before and after the experiment in 
each cardiomyocyte (see Figure 1A and16). As shown in Figure 1B and 1C, superfusion 
of resting cells with 1 µM isoproterenol (Iso) increased the frequency of Ca2+ sparks 
around 4-fold within 3 min, without significantly altering the [Ca2+]SR in this time window 
(see Figure 1E and16). Next, cAMP was raised independently of the β-AR receptors by 
direct activation of adenylate cyclase with forskolin.11 Surprisingly, and unlike Iso, 1 µM 
forskolin did not change the Ca2+ spark frequency significantly, even though the SR 
content increased to 125 %, presumably resulting from SERCA stimulation without 
activation of sparks in parallel. Importantly, both drugs resulted in almost identical 
amplification of the L-type Ca2+ current (ICa), confirming that forskolin activated PKA to 
an extent corresponding to Iso application (Figure 1D). Inclusion of the specific PKA 
inhibitory peptide PKI in the patch solution did not prevent the increase in the Ca2+ spark 
frequency, but resulted in a drop of SR Ca2+ content, presumably resulting from the 
suppression of SERCA stimulation during Iso. 
These results indicate that acute β-AR stimulation increases Ca2+ spark frequency, 
independently of cAMP and therefore makes an involvement of PKA and Epac very 
unlikely. Hence, we did not follow up on either of these pathways. A potential alternative 
pathway could be CaMKII, despite the fact that in quiescent cells, there were no Ca2+ 
signals that could activate this kinase. To confirm involvement of CaMKII, as also 
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suggested by our previous study,16 we carried out experiments in the presence of either 
KN-93 or KN-92 or included 10 µM of the specific CaMKII inhibitor autocamtide-2-related 
inhibitory peptide (AIP) in the patch solution. KN-93 and AIP prevented the increase in 
Ca2+ spark frequency in Iso without changing the SR Ca2+ content (Figure 2A-C). KN-92, 
the inactive negative control for KN-93, did not suppress the increase in spark frequency, 
as expected. Thus, under these experimental conditions, we can use the Ca2+ spark 
frequency as biological indicator for CaMKII activity. 
 
 
3.2 ROS scavengers fail to prevent the increase in Ca2+ spark frequency 
 
We then examined whether Ca2+-independent CaMKII activation by ROS23 could 
underlie the higher spark frequency. For this we used Mn-TBAP, a superoxide dismutase 
(SOD) mimetic, which has previously been shown in our experiments to reliably 
suppress Ca2+ sparks initiated by oxidative stress.25 Interestingly, 100 µM Mn-TBAP 
failed to prevent the increase in Ca2+ spark frequency and did not significantly alter SR 
Ca2+ load (Figure 2D-F), indicating that CaMKII activation by β-AR stimulation is not 
ROS-dependent. 
 
 
3.3 NO modulates Ca2+ spark frequency upon β-AR stimulation 
 
It has been suggested that after β-AR stimulation the increase in SR Ca2+ leak, 
determined with a dedicated leak protocol, is dependent on NO production and 
independent of PKA, because NO-synthase (NOS) inhibition prevented the leak 
observed in the presence of Iso.11,26 To examine whether a similar mechanism could be 
involved in the higher frequency of Ca2+ spark observed here, we inhibited the synthesis 
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of NO while stimulating the cardiomyocytes with Iso, analogous to experiments 
described in Figure 1. Pretreatment with 500 µM of the NOS inhibitor L-NAME prevented 
a significant increase in Ca2+ spark frequency (Figure 3A), indicating that upon β-AR 
stimulation, the spark frequency is modulated by endogenous NO produced by NOS of 
the cardiomyocyte.  
To confirm NO involvement, cells were loaded with diaminofluorescein (DAF-2) by 
exposure to the ester (DAF-2DA; 0.1 µM). After application of Iso, we recorded a 
substantial increase in DAF-2 fluorescence (19% ± 5%; Figure 3C and E). In some cells 
the NO donor S-Nitroso-L-glutathione (GSNO; 500 µM) was added at the end of the 
protocol, to confirm that DAF-2 resolves NO signals (Figure 3D). Please note that these 
recordings were corrected for dye bleaching and should not be taken quantitatively for 
NO concentrations. Because DAF-2 has been reported to detect other types of reactive 
species27, we repeated the same experiment in 500 µM L-NAME to suppress NO 
formation. This prevented the increase in DAF-2 fluorescence (Figure 3E and 3F, orange 
symbols and columns), confirming that the signal reflects NO production. Cellular ROS 
production induced by GSNO was excluded with the ROS sensitive fluorescent indicator 
CM-H2DCF (see supplementary Figure S1). Together these findings firmly establish a 
link between Iso-induced production of intracellular NO by the cardiomyocytes and the 
observed increase of Ca2+ spark frequencies mediated by CaMKII. This interpretation is 
in line with the inability of Mn-TBAP to prevent the increase in Ca2+ spark frequency 
(Figure 2D and 2E) and is consistent with the observation that Mn-TBAP does not 
significantly scavenge NO.28 
 
 
3.4 The NO donor GSNO reproduces the increase in Ca2+ spark frequency induced 
by β-adrenergic stimulation 
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NO can affect the function of proteins, including the RyRs, via several known 
pathways.29-31 This can occur directly as post-translational protein modifications, such as 
S-nitrosation (also referred to as S-nitrosylation or transnitrosylation).12,32 Alternatively, 
NO can lead to the formation of cGMP and activation of protein kinase G (PKG), which 
has been shown to phosphorylate RyRs, but so far only in-vitro.33 The findings in Figure 
3 indicate that after Iso application, NO mediates the increase in Ca2+ spark frequency. 
To support this interpretation, we used a NO donor instead of Iso. 150 µM GSNO 
resulted in a 3.22 (± 0.31)-fold increase in Ca2+ spark frequency, thereby quantitatively 
mimicking the changes observed in Iso (Figure 4A and 4B). Note that in these 
experiments SR Ca2+ content did not maintain the control level, presumably because 
GSNO increased the Ca2+ spark frequency without concomitant SERCA stimulation 
(Figure 4C). To distinguish between a direct S-nitrosation of the RyRs and an indirect 
modification via CaMKII (suggested by the findings above), we tested whether AIP could 
prevent the GSNO-dependent occurrence of sparks, similar to what was observed in Iso. 
In the presence of AIP, GSNO did not significantly elevate spark frequency (Figure 4B). 
These findings confirm that the higher spark frequency in GSNO resulted largely from 
activation of CaMKII and not from a direct S-nitrosation of the RyRs or activation of PKG. 
In summary, these data indicate that NO can activate CaMKII, in the absence of Ca2+ 
signals. 
 
3.5 Quantification of NO-dependent CaMKII activation in-vitro 
To confirm that NO could activate CaMKII in the absence of elevated Ca2+, we used an 
in-vitro assay.34 CaMKII activity was detected with an ELISA test and normalized to that 
observed in low Ca2+ (< 10 nM; Ca2+, CaM and EGTA, Figure 4D). As already 
established,23 addition of H2O2 activated CaMKII in low Ca2+. The activity observed in 1 
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µM H2O2 was 2.65 (± 0.47)-fold higher than in control. The NO donor GSNO resulted in 
comparable CaMKII stimulation of 2.31 (± 0.39)-fold. CaMKII activity under these 
oxidative and nitrosative conditions represented ~16% of the maximal Ca2+/CaM 
dependent activity (250 µM Ca2 and 120 nM calmodulin). This confirms a direct 
activation of CaMKII by NO, as suggested by our findings in cardiomyocytes. 
Each CaMKII monomer is predicted by GPS-SNO software35 to have 3 potential sites for 
S-nitrosation (Figure 4E upper panel). We used an antibody specifically recognizing S-
nitrosated cysteines to quantify CaMKII nitrosation after pre-incubation of CaMKIIδ with 
GSNO (Figure 4E lower panel). Indeed, a 32.1% ± 13% increase of CaMKII nitrosation 
was observed with this assay. 
 
 
3.6 GSNO leads to arrhythmogenic Ca2+ signals In beating cardiomyocytes 
At the cellular level, spontaneous Ca2+ waves (SCWS) are considered to be indicators 
for arrhythmogenic conditions. Since the elevated Ca2+ spark frequencies shown above 
could result in SCWS, we tested the arrhythmogenic potential of the NO donor in field 
stimulated cardiomyocytes (Figure 5). In these experiments, NO presumably modifed 
several relevant Ca2+ signaling proteins and membrane channels. However, the 
recordings revealed an increase in the diastolic Ca2+ spark frequency, similar to what 
was observed in resting cells. Furthermore, after a train of 10 depolarizations, 13.3% of 
the control myocytes exhibited SCWS, while in the presence of GSNO 77.8% showed 
waves. This elevated wave frequency was accompanied by a reduced SR content (to 
77% ± 6.5% of control), confirming that the waves were resulting from altered function of 
the RyRs and not from SR Ca2+ overload.  
Taken together, our results provide compelling evidence that the observed increase in 
Ca2+ spark frequency upon β-AR stimulation results from an activation of CaMKII, which 
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is mediated by NO but is not dependent on Ca2+ transients (see Figure 6 for a diagram of 
this pathway). This represents a new mechanism for CaMKII activation that may have far 
reaching implications. 
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4. Discussion 
 
 
RyRs have attracted considerable research interest, due to discoveries such as RyR 
mutations causing life threatening arrhythmias.36 alterations of their behavior during 
several diseases, which are often caused by posttranslational modifications, most 
notable phosphorylation and oxidation/nitrosation (for review see12). The participation of 
the RyRs in diseases such as catecholaminergic polymorphic ventricular tachycardias 
(CPVTs) and heart failure suggests that they may be potential drug targets.37,38 
 
 
4.1 Modulation of RyR function 
 
Changes of RyR function are expected to have a significant impact on cardiac Ca2+ 
signaling. Several laboratories have examined functional consequences of RyR 
phosphorylation on various levels of complexity, from single channels to isolated cells, 
partly using transgenic animal and disease models.7,39,40 These studies have resulted in 
a considerable controversy and confusion regarding the functional role of the involved 
protein kinases PKA and CaMKII.14,41 The reasons for this are not clear, but may arise 
from different disease models, protocols and experimental designs. As suggested by the 
present study, they may partly arise from unexpected cross-talks between complex 
cellular signaling pathways. 
 
 
4.2 Modes of CaMKII activation 
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When examining the importance of protein kinases for changes of diastolic Ca2+ spark 
frequencies after β-AR stimulation, we made a surprising observation. Even though there 
were no visible Ca2+ signals in resting cells that could lead to significant CaMKII 
activation, the increase in Ca2+ spark frequencies could be prevented by 
pharmacologically blocking CaMKII (but not PKA). This immediately raised the question 
how under these circumstances CaMKII could become activated? In the literature, 
several possibilities have been reported, including a pathway involving “exchange factor 
directly activated by cAMP” (Epac),15,42 or requiring oxidative modification of the 
CaMKII.23 The observation that the application of forskolin did not elevate the propensity 
of diastolic Ca2+ sparks, unlike β-AR stimulation, is in line with our conclusion, based on 
the experiments with protein kinase inhibitors for CaMKII and PKA, that any PKA 
involvement is highly unlikely. Furthermore, the negative result with forskolin regarding 
spark frequencies makes activation of CaMKII via the Epac pathway improbable and is 
consistent with the finding that forskolin does not increase SR Ca2+ leak.11 Therefore, we 
carried out experiments to test for the second possibility of Ca2+ spark activation, 
oxidative stress. Of note, redox modifications of the RyRs are well known to increase 
their openings43,44 although direct RyR oxidation would not be sensitive to the CaMKII 
inhibitor AIP, as observed in this study. Thus, we were left with the alternative that an 
oxidative modification of CaMKII could be responsible for its activation. However, we 
were unable to prevent the Ca2+ sparks with Mn-TBAP, a SOD mimetic which we found 
to reliably suppress ROS induced sparks in a model of oxidative stress.25 This finding 
suggests that ROS generation after β-AR stimulation is not involved in CaMKII activation 
and is consistent with a recent report showing that ROS production does not increase 
during β-AR stimulation of resting cells.45 
 
 
4.3 NO activates CaMKII in cardiomyocytes 
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An interesting observation has been reported in a study examining SR Ca2+ leaks in 
cardiomyocytes during β-AR stimulation using a dedicated leak protocol.11 In this study, 
the SR Ca2+ leak has been quantified from the drop of the cytosolic Ca2+ concentration 
after blocking the RyRs with tetracaine. These authors showed that the function of 
CaMKII, but also NO synthases, were important determinants for the SR Ca2+ leak.26 
Surprisingly, our experiments along these lines revealed that inhibition of NOS also 
prevented the increase in spark frequency, suggesting an involvement of NO signaling. 
To confirm a key role of NO we used a multi-pronged approach. We were able to detect 
endogenous NO production by the cardiomyocytes upon Iso application, while the NO 
donor GSNO mimicked the effects of Iso on the spark frequency. In contrast, the GSNO 
effect was almost completely inhibited by the specific CaMKII inhibitor AIP, suggesting 
that direct RyR nitrosation was not involved. Rather this appeared to be mainly mediated 
by CaMKII. Could it be that NO maintains CaMKII active at resting Ca2+ concentrations, 
similar to what has been reported for ROS?23 For this to occur, an initial Ca2+-dependent 
activation of CaMKII is required, which could be mediated by invisible Ca2+ signals, such 
as the Ca2+ quarks suggested to underlie a fraction of the SR Ca2+ leak.46,47 To address 
the intriguing question of NO-dependent CaMKII activation directly, we applied a 
biochemical in-vitro assay of CaMKII activity. The results obtained confirmed that NO 
can maintain CaMKII active to an extent similar to H2O2, without requiring elevated Ca2+ 
concentrations. Since this occurred in-vitro and was initiated by significant S-nitrosation 
of the CaMKII protein, it seems very likely that NO can directly activate CaMKII. 
Interestingly, a strikingly different regulation by NO and ROS has been reported for the 
CaMKIIα isoform of this kinase in pituitary tumor GH3 cells. This isoform was inhibited 
after nitrosation, but became activated in reducing conditions.48 
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4.4 Relevance of NO-dependent CaMKII activation 
 
Taken together, these findings provide compelling evidence for a stimulation of 
endogenous NO generation by cardiomyocytes upon β-AR stimulation. In the beating 
heart, this presumably additive mechanism may be even more pronounced, since further 
CaMKII activation will occur by enhanced Ca2+ transients. Several studies have 
previously reported positive or negative inotropic effects of NO, which may be partly 
related to modifications of CaMKII and RyR function, involved NOS isoforms, or 
crosstalk between activated pathways.49,50 Related to this, it has been suggested that 
NO may have a biphasic effect on RyR open probability, depending on the extent of pre-
existing β-AR stimulation.51 Although the precise mechanism of this phenomenon 
remains unresolved, it may involve CaMKII and could be related to changes of the 
nitroso/redox balance, as several posttranslational modifications will modulate RyR 
function in an exceedingly complex fashion.52  
The pathway characterized here represents a newly discovered mechanism for CaMKII 
activation. This results in a surge of diastolic Ca2+ sparks and increased wave 
propensity. Since Ca2+ sparks are signals faithfully reporting the function of the RyRs, 
this likely occurs via CaMKII-dependent modulation of the RyRs. In addition, the direct 
activation of CaMKII by NO observed here and the pathways participating downstream 
of CaMKII are expected to have additional repercussions for cardiomyocyte Ca2+ 
signaling. For example, NO mediated CaMKII activation contributes to the modulation of 
Ca2+ cycling upon β-AR stimulation, such as during physical exercise or emotional 
stress. During sustained β-AR stimulation, such as during heart failure, this could lead to 
SR Ca2+ depletion, weaker heart beat and arrhythmias.40,53 The additional CaMKII 
activation prompted by NO may be particularly detrimental if it occurs in conditions with 
already hypersensitive RyRs, for example in the presence of CPVT mutations or 
oxidative RyR modifications. 
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Finally, the identification of this pathway adds to the experimental complexity of studies 
with cardiac muscle because it represents a possibility for crosstalk between PKA and 
CaMKII activation, downstream of β-AR stimulation. The existence of such a cross-talk 
may explain some of the controversial experimental results and interpretations regarding 
the regulation of the RyRs by PKA or CaMKII respectively. 
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Figure Legends 
 
 
Figure 1 The increase of Ca2+ spark frequency by Iso is mediated by β-adrenergic 
receptors but not by cAMP. (A) The experimental protocol used trains of depolarizations 
to load the SR with Ca2+ and caffeine to estimate SR Ca2+ content (for details see 
Supplementary online information). (B) Confocal line-scan images showing Ca2+ sparks 
in control solution (Ctrl) and after ~3 min of 1 µM Iso or 1 µM forskolin. (C), Normalized 
Ca2+ spark frequency in Ctrl, after ~3 min of Iso (n=8, N=8) or forskolin (n=6, N=2) and 
after Iso in the presence of the PKA inhibitor PKI (n=7, N=3), respectively. In control, 
Ca2+ sparks are relatively indistinct and sparse in resting guinea pig cardiomyocytes16 
(around 1 s-1 100 µm-1). While Iso led to a ~4 fold increase in Ca2+ spark frequency, this 
was not observed with forskolin and was not prevented by the PKA inhibitor PKI. (D) 
Ca2+ current in Ctrl and after ~3 min Iso or forskolin. For this experiment the cells were 
held at -40 mV to inactivate Na+ currents. Normalized Ca2+ current in Iso (n=5, N=4) or 
forskolin (n=6, N=5). Current stimulation by forskolin was similar to that by Iso, 
documenting comparable PKA activation. (E) Typical SR Ca2+ content assessment by 10 
mM caffeine. In forskolin, SR content is increased to 125% ± 8.8% (n=15, N=5) because 
of SERCA stimulation without activation of sparks. In contrast, in PKI the SR Ca2+ 
content decreased, partly because PKA inhibition prevents SERCA stimulation. 
 
Figure 2 CaMKII is involved in spark frequency modulation, but not via ROS-dependent 
CaMKII activation. (A) Line-scan images in Ctrl and after 1 µM Iso, both in the presence 
of 10 µM of AIP in the patch pipette. (B) Ca2+ spark frequency in Ctrl and in Iso, in the 
absence (n=8, N=8) or presence of the CaMKII inhibitors AIP (n=9, N=5), KN-93 (n=5, 
N=2) and its inactive analogue KN-92 (n=5, N=3). (C) Unchanged SR Ca2+ content in the 
presence of AIP, KN-93 and KN-92. (D) Line-scan images recorded after 1 hour pre-
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incubation with 100 µM ROS scavenger Mn-TBAP in Ctrl and after ~3 min of 1 µM Iso. 
(E) Ca2+ spark frequency during Iso without (n=8, N=8) and with Mn-TBAP (n=5, N=5 ). 
(F) Unchanged SR Ca2+ content in the presence of the ROS scavenger Mn-TBAP. 
Figure 3 The increase of Ca2+ spark frequency is dependent on NO. (A) Comparison of 
the Ca2+ spark frequency stimulation by 1 µM Iso without (n=8, N=8) and with (n=7, N=5) 
1 hour pre-incubation with 500 µM L-NAME. (B) SR Ca2+ content remained unchanged in 
the presence of L-NAME. (C) Representative signal of DAF-2 fluorescence before (Ctrl) 
and after ~3 min of 1 µM Iso. (D) Representative time-course of NO production upon 1 
µM Iso application. At the end, GSNO is applied as a positive control for NO detection. 
(E) Averaged time-course of DAF-2 fluorescence in Ctrl and during Iso recorded in the 
absence (red trace n=7, N=6) and presence of L-NAME (orange trace, n=6, N=4). (F) 
Normalized NO-induced DAF-2 fluorescence upon Iso (red bar) and after pre-incubation 
in 500 µM L-NAME (orange bar). L-NAME prevented the NO signal observed in control, 
confirming that the DAF-2 fluorescence resulted from NO production. 
 
 
Figure 4. The NO donor GSNO increases Ca2+ spark frequency upon CaMKII activation 
via nitrosation. (A) Line-scan images of Ca2+ spark recordings in Ctrl (top), during 150 
µM GSNO alone (middle) and GSNO in the presence of 10 µM AIP in the patch pipette 
(bottom). (B) Normalized spark frequencies after ~3 min of 1 µM Iso (blue bar n=6, N=6 ) 
and GSNO alone (red bar n=14 N=11) and with 10 µM AIP (white bar n=9 N=4). 
Inhibiting CaMKII with AIP prevented the higher frequency induced by GSNO. (C) After 
GSNO, the SR Ca2+ content was not maintained (83% ±6% of control) due to a higher 
spark frequency without SERCA stimulation in parallel. (D) Quantitative in-vitro CaMKII 
activation in response to 1 µM H2O2 (blue bar) or 500 µM GSNO (red bar) in comparison 
to control (white bar). CaMKII activities were normalized to full Ca2+/CaM-dependent and 
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control activities (N=5). (E) Detection of nitrosated CaMKII in-vitro by anti-Cys-SNO 
specific antibody reveals increased nitrosation in GSNO. 
 
 
Figure 5. In beating cardiomyocytes, the NO donor GSNO increased diastolic Ca2+ 
spark frequency and induced arrhythmogenic diastolic Ca2+ waves. (A) Protocol used to 
record Ca2+ transients and Ca2+ waves from myocytes during and immediately after 
stimulation, with or without the presence of GSNO. (B) GSNO resulted in more diastolic 
Ca2+ sparks,(C) in a higher propensity for spontaneous Ca2+ waves (SCWS) and (D) in 
reduced SR Ca2+ content. (E) Statistical analysis of SCWS (n=9, N=5) and SR content 
(n=9, N=5). 
 
 
Figure 6. Diagram of the involved pathways during β-AR stimulation of resting 
cardiomyocytes. Our results show that during β-AR stimulation by Iso, endogenous 
production of NO derived from NOS activates CaMKII and subsequently modulates the 
RyRs open probability, as reflected by the higher Ca2+ spark frequency. 
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